GBR 830—human monoclonal IgG1 antibody specific to OX40 (CD 134). GBR 830 was assessed in a phase Iia, randomized, double-blind, and placebo-controlled study in AD patients. Here, TNFRSF4 is linked to Alzheimer disease.